Pharma & Healthcare
Global Imatinib Drug Market Research Report 2025
- Sep 09, 25
- ID: 497011
- Pages: 78
- Figures: 82
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Imatinib Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Drug.
The Imatinib Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Imatinib Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imatinib Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
Segment by Type
Tablets
Capsules
Segment by Application
Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Imatinib Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Imatinib Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Imatinib Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Drug.
The Imatinib Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Imatinib Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imatinib Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
Segment by Type
Tablets
Capsules
Segment by Application
Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Imatinib Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Imatinib Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Imatinib Drug Market Overview
1.1 Product Definition
1.2 Imatinib Drug by Type
1.2.1 Global Imatinib Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Capsules
1.3 Imatinib Drug by Application
1.3.1 Global Imatinib Drug Market Value by Application (2024 VS 2031)
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Global Imatinib Drug Market Size Estimates and Forecasts
1.4.1 Global Imatinib Drug Revenue 2020-2031
1.4.2 Global Imatinib Drug Sales 2020-2031
1.4.3 Global Imatinib Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Imatinib Drug Market Competition by Manufacturers
2.1 Global Imatinib Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Imatinib Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Imatinib Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Imatinib Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Imatinib Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Imatinib Drug, Product Type & Application
2.7 Global Key Manufacturers of Imatinib Drug, Date of Enter into This Industry
2.8 Global Imatinib Drug Market Competitive Situation and Trends
2.8.1 Global Imatinib Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Imatinib Drug Players Market Share by Revenue
2.8.3 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Imatinib Drug Market Scenario by Region
3.1 Global Imatinib Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Imatinib Drug Sales by Region: 2020-2031
3.2.1 Global Imatinib Drug Sales by Region: 2020-2025
3.2.2 Global Imatinib Drug Sales by Region: 2026-2031
3.3 Global Imatinib Drug Revenue by Region: 2020-2031
3.3.1 Global Imatinib Drug Revenue by Region: 2020-2025
3.3.2 Global Imatinib Drug Revenue by Region: 2026-2031
3.4 North America Imatinib Drug Market Facts & Figures by Country
3.4.1 North America Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Imatinib Drug Sales by Country (2020-2031)
3.4.3 North America Imatinib Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Imatinib Drug Market Facts & Figures by Country
3.5.1 Europe Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Imatinib Drug Sales by Country (2020-2031)
3.5.3 Europe Imatinib Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Imatinib Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Imatinib Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Imatinib Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Imatinib Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Imatinib Drug Market Facts & Figures by Country
3.7.1 Latin America Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Imatinib Drug Sales by Country (2020-2031)
3.7.3 Latin America Imatinib Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Imatinib Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Imatinib Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Imatinib Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Imatinib Drug Sales by Type (2020-2031)
4.1.1 Global Imatinib Drug Sales by Type (2020-2025)
4.1.2 Global Imatinib Drug Sales by Type (2026-2031)
4.1.3 Global Imatinib Drug Sales Market Share by Type (2020-2031)
4.2 Global Imatinib Drug Revenue by Type (2020-2031)
4.2.1 Global Imatinib Drug Revenue by Type (2020-2025)
4.2.2 Global Imatinib Drug Revenue by Type (2026-2031)
4.2.3 Global Imatinib Drug Revenue Market Share by Type (2020-2031)
4.3 Global Imatinib Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Imatinib Drug Sales by Application (2020-2031)
5.1.1 Global Imatinib Drug Sales by Application (2020-2025)
5.1.2 Global Imatinib Drug Sales by Application (2026-2031)
5.1.3 Global Imatinib Drug Sales Market Share by Application (2020-2031)
5.2 Global Imatinib Drug Revenue by Application (2020-2031)
5.2.1 Global Imatinib Drug Revenue by Application (2020-2025)
5.2.2 Global Imatinib Drug Revenue by Application (2026-2031)
5.2.3 Global Imatinib Drug Revenue Market Share by Application (2020-2031)
5.3 Global Imatinib Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Imatinib Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Glenmark Pharmaceuticals Ltd.
6.2.1 Glenmark Pharmaceuticals Ltd. Company Information
6.2.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
6.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Portfolio
6.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
6.3 Sun Pharmaceuticals
6.3.1 Sun Pharmaceuticals Company Information
6.3.2 Sun Pharmaceuticals Description and Business Overview
6.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sun Pharmaceuticals Imatinib Drug Product Portfolio
6.3.5 Sun Pharmaceuticals Recent Developments/Updates
6.4 Actavis Generics
6.4.1 Actavis Generics Company Information
6.4.2 Actavis Generics Description and Business Overview
6.4.3 Actavis Generics Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Actavis Generics Imatinib Drug Product Portfolio
6.4.5 Actavis Generics Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr. Reddy's Laboratories Imatinib Drug Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd.
6.6.1 Teva Pharmaceutical Industries Ltd. Company Information
6.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.7 Sanofi S.A.
6.7.1 Sanofi S.A. Company Information
6.7.2 Sanofi S.A. Description and Business Overview
6.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi S.A. Imatinib Drug Product Portfolio
6.7.5 Sanofi S.A. Recent Developments/Updates
6.8 Cipla Inc.
6.8.1 Cipla Inc. Company Information
6.8.2 Cipla Inc. Description and Business Overview
6.8.3 Cipla Inc. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cipla Inc. Imatinib Drug Product Portfolio
6.8.5 Cipla Inc. Recent Developments/Updates
6.9 Apotex Inc.
6.9.1 Apotex Inc. Company Information
6.9.2 Apotex Inc. Description and Business Overview
6.9.3 Apotex Inc. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Apotex Inc. Imatinib Drug Product Portfolio
6.9.5 Apotex Inc. Recent Developments/Updates
6.10 Mylan Pharms Inc.
6.10.1 Mylan Pharms Inc. Company Information
6.10.2 Mylan Pharms Inc. Description and Business Overview
6.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mylan Pharms Inc. Imatinib Drug Product Portfolio
6.10.5 Mylan Pharms Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Imatinib Drug Industry Chain Analysis
7.2 Imatinib Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Imatinib Drug Production Mode & Process Analysis
7.4 Imatinib Drug Sales and Marketing
7.4.1 Imatinib Drug Sales Channels
7.4.2 Imatinib Drug Distributors
7.5 Imatinib Drug Customer Analysis
8 Imatinib Drug Market Dynamics
8.1 Imatinib Drug Industry Trends
8.2 Imatinib Drug Market Drivers
8.3 Imatinib Drug Market Challenges
8.4 Imatinib Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Imatinib Drug by Type
1.2.1 Global Imatinib Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Capsules
1.3 Imatinib Drug by Application
1.3.1 Global Imatinib Drug Market Value by Application (2024 VS 2031)
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Global Imatinib Drug Market Size Estimates and Forecasts
1.4.1 Global Imatinib Drug Revenue 2020-2031
1.4.2 Global Imatinib Drug Sales 2020-2031
1.4.3 Global Imatinib Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Imatinib Drug Market Competition by Manufacturers
2.1 Global Imatinib Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Imatinib Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Imatinib Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Imatinib Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Imatinib Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Imatinib Drug, Product Type & Application
2.7 Global Key Manufacturers of Imatinib Drug, Date of Enter into This Industry
2.8 Global Imatinib Drug Market Competitive Situation and Trends
2.8.1 Global Imatinib Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Imatinib Drug Players Market Share by Revenue
2.8.3 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Imatinib Drug Market Scenario by Region
3.1 Global Imatinib Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Imatinib Drug Sales by Region: 2020-2031
3.2.1 Global Imatinib Drug Sales by Region: 2020-2025
3.2.2 Global Imatinib Drug Sales by Region: 2026-2031
3.3 Global Imatinib Drug Revenue by Region: 2020-2031
3.3.1 Global Imatinib Drug Revenue by Region: 2020-2025
3.3.2 Global Imatinib Drug Revenue by Region: 2026-2031
3.4 North America Imatinib Drug Market Facts & Figures by Country
3.4.1 North America Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Imatinib Drug Sales by Country (2020-2031)
3.4.3 North America Imatinib Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Imatinib Drug Market Facts & Figures by Country
3.5.1 Europe Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Imatinib Drug Sales by Country (2020-2031)
3.5.3 Europe Imatinib Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Imatinib Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Imatinib Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Imatinib Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Imatinib Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Imatinib Drug Market Facts & Figures by Country
3.7.1 Latin America Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Imatinib Drug Sales by Country (2020-2031)
3.7.3 Latin America Imatinib Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Imatinib Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Imatinib Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Imatinib Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Imatinib Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Imatinib Drug Sales by Type (2020-2031)
4.1.1 Global Imatinib Drug Sales by Type (2020-2025)
4.1.2 Global Imatinib Drug Sales by Type (2026-2031)
4.1.3 Global Imatinib Drug Sales Market Share by Type (2020-2031)
4.2 Global Imatinib Drug Revenue by Type (2020-2031)
4.2.1 Global Imatinib Drug Revenue by Type (2020-2025)
4.2.2 Global Imatinib Drug Revenue by Type (2026-2031)
4.2.3 Global Imatinib Drug Revenue Market Share by Type (2020-2031)
4.3 Global Imatinib Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Imatinib Drug Sales by Application (2020-2031)
5.1.1 Global Imatinib Drug Sales by Application (2020-2025)
5.1.2 Global Imatinib Drug Sales by Application (2026-2031)
5.1.3 Global Imatinib Drug Sales Market Share by Application (2020-2031)
5.2 Global Imatinib Drug Revenue by Application (2020-2031)
5.2.1 Global Imatinib Drug Revenue by Application (2020-2025)
5.2.2 Global Imatinib Drug Revenue by Application (2026-2031)
5.2.3 Global Imatinib Drug Revenue Market Share by Application (2020-2031)
5.3 Global Imatinib Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Imatinib Drug Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Glenmark Pharmaceuticals Ltd.
6.2.1 Glenmark Pharmaceuticals Ltd. Company Information
6.2.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
6.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Portfolio
6.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
6.3 Sun Pharmaceuticals
6.3.1 Sun Pharmaceuticals Company Information
6.3.2 Sun Pharmaceuticals Description and Business Overview
6.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sun Pharmaceuticals Imatinib Drug Product Portfolio
6.3.5 Sun Pharmaceuticals Recent Developments/Updates
6.4 Actavis Generics
6.4.1 Actavis Generics Company Information
6.4.2 Actavis Generics Description and Business Overview
6.4.3 Actavis Generics Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Actavis Generics Imatinib Drug Product Portfolio
6.4.5 Actavis Generics Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr. Reddy's Laboratories Imatinib Drug Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd.
6.6.1 Teva Pharmaceutical Industries Ltd. Company Information
6.6.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.7 Sanofi S.A.
6.7.1 Sanofi S.A. Company Information
6.7.2 Sanofi S.A. Description and Business Overview
6.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi S.A. Imatinib Drug Product Portfolio
6.7.5 Sanofi S.A. Recent Developments/Updates
6.8 Cipla Inc.
6.8.1 Cipla Inc. Company Information
6.8.2 Cipla Inc. Description and Business Overview
6.8.3 Cipla Inc. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cipla Inc. Imatinib Drug Product Portfolio
6.8.5 Cipla Inc. Recent Developments/Updates
6.9 Apotex Inc.
6.9.1 Apotex Inc. Company Information
6.9.2 Apotex Inc. Description and Business Overview
6.9.3 Apotex Inc. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Apotex Inc. Imatinib Drug Product Portfolio
6.9.5 Apotex Inc. Recent Developments/Updates
6.10 Mylan Pharms Inc.
6.10.1 Mylan Pharms Inc. Company Information
6.10.2 Mylan Pharms Inc. Description and Business Overview
6.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mylan Pharms Inc. Imatinib Drug Product Portfolio
6.10.5 Mylan Pharms Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Imatinib Drug Industry Chain Analysis
7.2 Imatinib Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Imatinib Drug Production Mode & Process Analysis
7.4 Imatinib Drug Sales and Marketing
7.4.1 Imatinib Drug Sales Channels
7.4.2 Imatinib Drug Distributors
7.5 Imatinib Drug Customer Analysis
8 Imatinib Drug Market Dynamics
8.1 Imatinib Drug Industry Trends
8.2 Imatinib Drug Market Drivers
8.3 Imatinib Drug Market Challenges
8.4 Imatinib Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Imatinib Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Imatinib Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Imatinib Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Imatinib Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Imatinib Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Imatinib Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Imatinib Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Imatinib Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Imatinib Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Imatinib Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Imatinib Drug, Product Type & Application
Table 12. Global Key Manufacturers of Imatinib Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Imatinib Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Imatinib Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Imatinib Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Imatinib Drug Sales Market Share by Region (2020-2025)
Table 19. Global Imatinib Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Imatinib Drug Sales Market Share by Region (2026-2031)
Table 21. Global Imatinib Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Imatinib Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Imatinib Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Imatinib Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Imatinib Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Imatinib Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Imatinib Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Imatinib Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Imatinib Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Imatinib Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Imatinib Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Imatinib Drug Sales Market Share by Type (2020-2025)
Table 53. Global Imatinib Drug Sales Market Share by Type (2026-2031)
Table 54. Global Imatinib Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Imatinib Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Imatinib Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Imatinib Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Imatinib Drug Price (USD/Unit) by Type (2020-2025)
Table 59. Global Imatinib Drug Price (USD/Unit) by Type (2026-2031)
Table 60. Global Imatinib Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Imatinib Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Imatinib Drug Sales Market Share by Application (2020-2025)
Table 63. Global Imatinib Drug Sales Market Share by Application (2026-2031)
Table 64. Global Imatinib Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Imatinib Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Imatinib Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Imatinib Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Imatinib Drug Price (USD/Unit) by Application (2020-2025)
Table 69. Global Imatinib Drug Price (USD/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Imatinib Drug Product
Table 74. Novartis Recent Developments/Updates
Table 75. Glenmark Pharmaceuticals Ltd. Company Information
Table 76. Glenmark Pharmaceuticals Ltd. Description and Business Overview
Table 77. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product
Table 79. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
Table 80. Sun Pharmaceuticals Company Information
Table 81. Sun Pharmaceuticals Description and Business Overview
Table 82. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sun Pharmaceuticals Imatinib Drug Product
Table 84. Sun Pharmaceuticals Recent Developments/Updates
Table 85. Actavis Generics Company Information
Table 86. Actavis Generics Description and Business Overview
Table 87. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Actavis Generics Imatinib Drug Product
Table 89. Actavis Generics Recent Developments/Updates
Table 90. Dr. Reddy's Laboratories Company Information
Table 91. Dr. Reddy's Laboratories Description and Business Overview
Table 92. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Dr. Reddy's Laboratories Imatinib Drug Product
Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd. Company Information
Table 96. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product
Table 99. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 100. Sanofi S.A. Company Information
Table 101. Sanofi S.A. Description and Business Overview
Table 102. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Sanofi S.A. Imatinib Drug Product
Table 104. Sanofi S.A. Recent Developments/Updates
Table 105. Cipla Inc. Company Information
Table 106. Cipla Inc. Description and Business Overview
Table 107. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cipla Inc. Imatinib Drug Product
Table 109. Cipla Inc. Recent Developments/Updates
Table 110. Apotex Inc. Company Information
Table 111. Apotex Inc. Description and Business Overview
Table 112. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Apotex Inc. Imatinib Drug Product
Table 114. Apotex Inc. Recent Developments/Updates
Table 115. Mylan Pharms Inc. Company Information
Table 116. Mylan Pharms Inc. Description and Business Overview
Table 117. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Mylan Pharms Inc. Imatinib Drug Product
Table 119. Mylan Pharms Inc. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Imatinib Drug Distributors List
Table 123. Imatinib Drug Customers List
Table 124. Imatinib Drug Market Trends
Table 125. Imatinib Drug Market Drivers
Table 126. Imatinib Drug Market Challenges
Table 127. Imatinib Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Imatinib Drug
Figure 2. Global Imatinib Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Imatinib Drug Market Share by Type: 2024 & 2031
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Imatinib Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Imatinib Drug Market Share by Application: 2024 & 2031
Figure 8. Chronic Myelogenous Leukemia
Figure 9. Gastrointestinal Stromal Tumors
Figure 10. Others
Figure 11. Global Imatinib Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Imatinib Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Imatinib Drug Sales (2020-2031) & (K Units)
Figure 14. Global Imatinib Drug Average Price (USD/Unit) & (2020-2031)
Figure 15. Imatinib Drug Report Years Considered
Figure 16. Imatinib Drug Sales Share by Manufacturers in 2024
Figure 17. Global Imatinib Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Imatinib Drug Players: Market Share by Revenue in Imatinib Drug in 2024
Figure 19. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Imatinib Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Imatinib Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Imatinib Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 45. Latin America Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Imatinib Drug by Type (2020-2031)
Figure 55. Global Revenue Market Share of Imatinib Drug by Type (2020-2031)
Figure 56. Global Imatinib Drug Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Imatinib Drug by Application (2020-2031)
Figure 58. Global Revenue Market Share of Imatinib Drug by Application (2020-2031)
Figure 59. Global Imatinib Drug Price (USD/Unit) by Application (2020-2031)
Figure 60. Imatinib Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Imatinib Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Imatinib Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Imatinib Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Imatinib Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Imatinib Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Imatinib Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Imatinib Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Imatinib Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Imatinib Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Imatinib Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Imatinib Drug, Product Type & Application
Table 12. Global Key Manufacturers of Imatinib Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Imatinib Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Imatinib Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Imatinib Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Imatinib Drug Sales Market Share by Region (2020-2025)
Table 19. Global Imatinib Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Imatinib Drug Sales Market Share by Region (2026-2031)
Table 21. Global Imatinib Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Imatinib Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Imatinib Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Imatinib Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Imatinib Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Imatinib Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Imatinib Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Imatinib Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Imatinib Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Imatinib Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Imatinib Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Imatinib Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Imatinib Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Imatinib Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Imatinib Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Imatinib Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Imatinib Drug Sales Market Share by Type (2020-2025)
Table 53. Global Imatinib Drug Sales Market Share by Type (2026-2031)
Table 54. Global Imatinib Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Imatinib Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Imatinib Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Imatinib Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Imatinib Drug Price (USD/Unit) by Type (2020-2025)
Table 59. Global Imatinib Drug Price (USD/Unit) by Type (2026-2031)
Table 60. Global Imatinib Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Imatinib Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Imatinib Drug Sales Market Share by Application (2020-2025)
Table 63. Global Imatinib Drug Sales Market Share by Application (2026-2031)
Table 64. Global Imatinib Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Imatinib Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Imatinib Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Imatinib Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Imatinib Drug Price (USD/Unit) by Application (2020-2025)
Table 69. Global Imatinib Drug Price (USD/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Imatinib Drug Product
Table 74. Novartis Recent Developments/Updates
Table 75. Glenmark Pharmaceuticals Ltd. Company Information
Table 76. Glenmark Pharmaceuticals Ltd. Description and Business Overview
Table 77. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product
Table 79. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
Table 80. Sun Pharmaceuticals Company Information
Table 81. Sun Pharmaceuticals Description and Business Overview
Table 82. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sun Pharmaceuticals Imatinib Drug Product
Table 84. Sun Pharmaceuticals Recent Developments/Updates
Table 85. Actavis Generics Company Information
Table 86. Actavis Generics Description and Business Overview
Table 87. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Actavis Generics Imatinib Drug Product
Table 89. Actavis Generics Recent Developments/Updates
Table 90. Dr. Reddy's Laboratories Company Information
Table 91. Dr. Reddy's Laboratories Description and Business Overview
Table 92. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Dr. Reddy's Laboratories Imatinib Drug Product
Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd. Company Information
Table 96. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product
Table 99. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 100. Sanofi S.A. Company Information
Table 101. Sanofi S.A. Description and Business Overview
Table 102. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Sanofi S.A. Imatinib Drug Product
Table 104. Sanofi S.A. Recent Developments/Updates
Table 105. Cipla Inc. Company Information
Table 106. Cipla Inc. Description and Business Overview
Table 107. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cipla Inc. Imatinib Drug Product
Table 109. Cipla Inc. Recent Developments/Updates
Table 110. Apotex Inc. Company Information
Table 111. Apotex Inc. Description and Business Overview
Table 112. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Apotex Inc. Imatinib Drug Product
Table 114. Apotex Inc. Recent Developments/Updates
Table 115. Mylan Pharms Inc. Company Information
Table 116. Mylan Pharms Inc. Description and Business Overview
Table 117. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Mylan Pharms Inc. Imatinib Drug Product
Table 119. Mylan Pharms Inc. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Imatinib Drug Distributors List
Table 123. Imatinib Drug Customers List
Table 124. Imatinib Drug Market Trends
Table 125. Imatinib Drug Market Drivers
Table 126. Imatinib Drug Market Challenges
Table 127. Imatinib Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Imatinib Drug
Figure 2. Global Imatinib Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Imatinib Drug Market Share by Type: 2024 & 2031
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Imatinib Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Imatinib Drug Market Share by Application: 2024 & 2031
Figure 8. Chronic Myelogenous Leukemia
Figure 9. Gastrointestinal Stromal Tumors
Figure 10. Others
Figure 11. Global Imatinib Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Imatinib Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Imatinib Drug Sales (2020-2031) & (K Units)
Figure 14. Global Imatinib Drug Average Price (USD/Unit) & (2020-2031)
Figure 15. Imatinib Drug Report Years Considered
Figure 16. Imatinib Drug Sales Share by Manufacturers in 2024
Figure 17. Global Imatinib Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Imatinib Drug Players: Market Share by Revenue in Imatinib Drug in 2024
Figure 19. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Imatinib Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Imatinib Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Imatinib Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 45. Latin America Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Imatinib Drug Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Imatinib Drug Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Imatinib Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Imatinib Drug by Type (2020-2031)
Figure 55. Global Revenue Market Share of Imatinib Drug by Type (2020-2031)
Figure 56. Global Imatinib Drug Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Imatinib Drug by Application (2020-2031)
Figure 58. Global Revenue Market Share of Imatinib Drug by Application (2020-2031)
Figure 59. Global Imatinib Drug Price (USD/Unit) by Application (2020-2031)
Figure 60. Imatinib Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232